SLGC
Somalogic IncKey Statistics
About Somalogic Inc
SomaLogic Inc. (SLGC) is a pioneering biotechnology company specializing in protein biomarker discovery and analysis, harnessing its proprietary SomaScan® platform to provide insights that advance precision medicine. By utilizing an extensive protein library, the company aims to develop sophisticated diagnostics and therapeutic applications across various health conditions, including cancer, cardiovascular diseases, and metabolic disorders. SomaLogic is positioned at the forefront of the biomarker industry, driving innovation in research and clinical settings while forming strategic partnerships to expand its reach and enhance the adoption of its technologies. With a strong focus on data-driven health solutions, SomaLogic is committed to improving patient outcomes and enabling personalized therapeutic strategies.
Fundamentals
| Revenue (TTM) | $81.72M |
| Gross Profit (TTM) | $-11.27M |
| EBITDA | $-134.86M |
| Operating Margin | -108.50% |
| Return on Equity | -23.70% |
| Return on Assets | -14.20% |
| Revenue/Share (TTM) | $0.44 |
| Book Value | $2.63 |
| Price-to-Book | 0.80 |
| Price-to-Sales (TTM) | 4.85 |
| EV/Revenue | 0.137 |
| EV/EBITDA | 0.69 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -47.10% |
| Shares Outstanding | $188.68M |
| Float | $153.26M |
| % Insiders | 2.16% |
| % Institutions | 61.71% |